96 related articles for article (PubMed ID: 1846799)
21. A morphometrical analysis of minute depressed adenomas in familial polyposis coli.
Kubota O; Kino I; Nakamura S
Pathol Int; 1994 Mar; 44(3):200-4. PubMed ID: 8025662
[TBL] [Abstract][Full Text] [Related]
22. p53 Protein overexpression in colorectal tumors from patients with familial adenomatous polyposis: is it an early or late event?
Levi E; Stryker SJ; Rao MS
Am J Gastroenterol; 1996 Jan; 91(1):11-4. PubMed ID: 8561108
[TBL] [Abstract][Full Text] [Related]
23. Familial adenomatous polyposis is associated with a marked decrease in alkaline sphingomyelinase activity: a key factor to the unrestrained cell proliferation?
Hertervig E; Nilsson A; Björk J; Hultkrantz R; Duan RD
Br J Cancer; 1999 Sep; 81(2):232-6. PubMed ID: 10496347
[TBL] [Abstract][Full Text] [Related]
24. [Application of serum protein markers to distinguish familial adenomatous polyposis (FAP) and sporadic colorectal adenomas].
Cai SR; Yu JK; Jiang WZ; Zhang SZ; Zheng S
Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):192-5. PubMed ID: 19615258
[TBL] [Abstract][Full Text] [Related]
25. A multi-stage model of adenoma development.
Pinsky PF
J Theor Biol; 2000 Nov; 207(2):129-43. PubMed ID: 11034825
[TBL] [Abstract][Full Text] [Related]
26. Estrogen Receptor β as a Prognostic Marker of Tumor Progression in Colorectal Cancer with Familial Adenomatous Polyposis and Sporadic Polyps.
Stevanato Filho PR; Aguiar Júnior S; Begnami MD; Ferreira FO; Nakagawa WT; Spencer RMSB; Bezerra TS; Boggiss PE; Lopes A
Pathol Oncol Res; 2018 Jul; 24(3):533-540. PubMed ID: 28681123
[TBL] [Abstract][Full Text] [Related]
27. Serrated adenoma in familial adenomatous polyposis: relation to germline APC gene mutation.
Matsumoto T; Iida M; Kobori Y; Mizuno M; Nakamura S; Hizawa K; Yao T
Gut; 2002 Mar; 50(3):402-4. PubMed ID: 11839722
[TBL] [Abstract][Full Text] [Related]
28. Morphology and genetics of pyloric gland adenomas in familial adenomatous polyposis.
Hackeng WM; Montgomery EA; Giardiello FM; Singhi AD; Debeljak M; Eshleman JR; Vieth M; Offerhaus GJ; Wood LD; Brosens LA
Histopathology; 2017 Mar; 70(4):549-557. PubMed ID: 27767239
[TBL] [Abstract][Full Text] [Related]
29. Loss of extracellular E-cadherin in the normal mucosa of duodenum and colon of patients with familial adenomatous polyposis.
Berkhout M; Gosens MJ; Brouwer KM; Peters WH; Nagengast FM; van Krieken JH; Nagtegaal ID
Hum Pathol; 2006 Nov; 37(11):1389-99. PubMed ID: 16949915
[TBL] [Abstract][Full Text] [Related]
30. Molecular analysis of sulindac-resistant adenomas in familial adenomatous polyposis.
Keller JJ; Offerhaus GJ; Drillenburg P; Caspers E; Musler A; Ristimäki A; Giardiello FM
Clin Cancer Res; 2001 Dec; 7(12):4000-7. PubMed ID: 11751493
[TBL] [Abstract][Full Text] [Related]
31. Germline APC mutation on the beta-catenin binding site is associated with a decreased apoptotic level in colorectal adenomas.
Venesio T; Balsamo A; Scordamaglia A; Bertolaso M; Arrigoni A; Sprujevnik T; Rossini FP; Risio M
Mod Pathol; 2003 Jan; 16(1):57-65. PubMed ID: 12527714
[TBL] [Abstract][Full Text] [Related]
32. Neoplasias of the colorectal crypts.
Rubio CA
Anticancer Res; 2005; 25(6C):4551-8. PubMed ID: 16334140
[TBL] [Abstract][Full Text] [Related]
33. APC or MUTYH mutations account for the majority of clinically well-characterized families with FAP and AFAP phenotype and patients with more than 30 adenomas.
Filipe B; Baltazar C; Albuquerque C; Fragoso S; Lage P; Vitoriano I; Mão de Ferro S; Claro I; Rodrigues P; Fidalgo P; Chaves P; Cravo M; Nobre Leitão C
Clin Genet; 2009 Sep; 76(3):242-55. PubMed ID: 19793053
[TBL] [Abstract][Full Text] [Related]
34. DNA aneuploidy and cell proliferation in familial adenomatous polyposis.
Quirke P; Dixon MF; Day DW; Fozard JB; Talbot IC; Bird CC
Gut; 1988 May; 29(5):603-7. PubMed ID: 2840361
[TBL] [Abstract][Full Text] [Related]
35. Characterization of two novel adenomatous polyposis coli (APC) gene mutations in patients with familial adenomatous polyposis (FAP).
Bapat B; Berk T; Mitri A; Cohen Z; Gallinger S; Stern H
Hum Mutat; 1994; 4(4):253-6. PubMed ID: 7866403
[TBL] [Abstract][Full Text] [Related]
36. Telomerase activity and p53 gene mutation in familial polyposis coli.
Ikeguchi M; Makino M; Kaibara N
Anticancer Res; 2000; 20(5C):3833-7. PubMed ID: 11268463
[TBL] [Abstract][Full Text] [Related]
37. APC gene mutations and colorectal adenomatosis in familial adenomatous polyposis.
Ficari F; Cama A; Valanzano R; Curia MC; Palmirotta R; Aceto G; Esposito DL; Crognale S; Lombardi A; Messerini L; Mariani-Costantini R; Tonelli F; Battista P
Br J Cancer; 2000 Jan; 82(2):348-53. PubMed ID: 10646887
[TBL] [Abstract][Full Text] [Related]
38. E-cadherin expression is homogeneously reduced in adenoma from patients with familial adenomatous polyposis: an immunohistochemical study of E-cadherin, beta-catenin and cyclooxygenase-2 expression.
Jungck M; Grünhage F; Spengler U; Dernac A; Mathiak M; Caspari R; Friedl W; Sauerbruch T
Int J Colorectal Dis; 2004 Sep; 19(5):438-45. PubMed ID: 14986031
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical characteristics of duodenal adenomas in familial adenomatous polyposis with special reference to cell kinetics.
Esaki M; Matsumoto T; Yao S; Nakamura S; Hirahashi M; Yao T; Iida M
Hum Pathol; 2005 Jan; 36(1):66-73. PubMed ID: 15712184
[TBL] [Abstract][Full Text] [Related]
40. Hereditary flat adenoma syndrome: a variant of familial adenomatous polyposis?
Lynch HT; Smyrk TC; Watson P; Lanspa SJ; Lynch PM; Jenkins JX; Rouse J; Cavalieri J; Howard L; Lynch J
Dis Colon Rectum; 1992 May; 35(5):411-21. PubMed ID: 1314729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
